Table 3. Cardiovascular complications.
| Cardiovascular complications | All patients (N=54) n (%) |
| Presence of cardiovascular complication | |
| No | 22 (40.70) |
| Yes | 32 (59.3) |
| Pulmonary hypertension | |
| No | 53 (98.1) |
| Yes | 1 (1.9) |
| Dilated left ventricle | |
| No | 45 (83.3) |
| Yes | 9 (16.7) |
| Tricuspid valve insufficiency | |
| No | 48 (88.9) |
| Yes | 6 (11.1) |
| Mitral valve insufficiency | |
| No | 50 (92.6) |
| Yes | 4 (7.4) |
| Hyperdynamic left ventricle | |
| No | 53 (98.1) |
| Yes | 1 (1.9) |
| Ventricular dysfunction | |
| No | 54 (100) |
| Yes | 0 (0) |
| Long QTc interval | |
| No | 8 (14.8) |
| Yes | 3 (5.6) |
| Not done | 43 (79.6) |
| Cardiomegaly | |
| No | 35 (64.8) |
| Yes | 18 (33.3) |
| Not done | 1 (1.9) |
| Increased systolic blood pressure >95th percentile | |
| No | 44 (81.5) |
| Yes | 10 (18.5) |